Anti-inflammatory diet linked to reduced risk of early death

Adhering to an anti-inflammatory diet was associated with lower risks of dying from any cause, dying from cardiovascular causes, and dying from cancer in a recent Journal of Internal Medicine study.

In the study of 68,273 Swedish men and women aged 45 to 83 years who were followed for 16 years, participants who most closely followed an anti-inflammatory diet had an 18% lower risk of all-cause mortality, a 20% lower risk of cardiovascular mortality, and a 13% lower risk of cancer mortality, when compared with those who followed the diet to a lesser degree. Smokers who followed the diet experienced even greater benefits when compared with smokers who did not follow the diet.

Anti-inflammatory foods consist of fruits and vegetables, tea, coffee, whole grain bread, breakfast cereal, low-fat cheese, olive oil and canola oil, nuts, chocolate, and moderate amounts of red wine and beer. Pro-inflammatory foods include unprocessed and processed red meat, organ meats, chips, and soft-drink beverages.

"Our dose-response analysis showed that even partial adherence to the anti-inflammatory diet may provide a health benefit," said lead author Dr. Joanna Kaluza, an associate professor at the Warsaw University of Life Sciences, in Poland.

###

Link to study: https://onlinelibrary.wiley.com/doi/abs/10.1111/joim.12823

Journal of Internal Medicine (JIM), with its International Advisory Board, has developed into a highly successful journal since it was launched in its revised form in 1989. With an Impact Factor of 7.980, Journal of Internal Medicine now ranks 10th among the 154 journals in the General & Internal Medicine category.

• Established in 1863.
• Features original clinical articles within the broad field of general and internal medicine and its sub-specialties.
• A fully international journal publishing articles in English from all over the world.
• Peer-reviewed and published in both print and online versions.

JIM also supports and organizes scientific meetings in the form of symposia within the scope of the journal.

Wiley is a global leader in education and scholarly research. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.